Taro patents expiration
1. Flo-pred patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7799331 | TARO | Oral suspension of prednisolone acetate |
Oct, 2028
(5 years from now) | |
Drugs and Companies using PREDNISOLONE ACETATE ingredient
Market Authorisation Date: 17 January, 2008
Treatment: Treatment of asthma; Treatment of allergic reactions
Dosage: SUSPENSION;ORAL
More Information on Dosage
FLO-PRED family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic